Serum sex hormone and gonadotropin concentrations in premenopausal women with multiple sclerosis
- 19 October 1989
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 226 (4) , 241-244
- https://doi.org/10.1111/j.1365-2796.1989.tb01387.x
Abstract
Grinsted L, Heltberg A, Hagen C, Djursing H (Department of Obstetrics and Gynecology, University Hospital of Copenhagen, Hvidovre, Department of Neurology Amtssygehuset, DK 4000 Roskilde and MS Rehabilitation Center. DK 4690 Haslev. and Department of Internal Medicine and Endocrinology, University Hospital of Odense, 5000 Odense, Denmark). Serum sex hormone and gonadotropin concentrations in premenopausal women with multiple sclerosis. Dysfunctions within the hypothalamic-pituitary-gonadal axis occur frequently among women with multiple sclerosis (MS) and may induce menstrual disturbances and subsequent infertility. We have measured serum concentrations of prolactin, gonadotropins and sex hormone binding globulin (SHBG) as well as free and bound oestrogen and androgen levels in 14 women of fertile age with MS. These women all displayed regular cycles without having experienced fertility problems. As controls 14 normal women with regular periods and ideal body weight of 91 % (range 80–101) were included. Serum from both groups was sampled during the early follicular phase. The MS-patients had significantly (P < 0.05) higher concentrations of prolactin, LH, FSH, total and free testosterone (P < 0.01) and a significantly lower serum concentration of oestrone sulphate (P < 0.01). The abnormal hormone concentrations were not related to clinical status of the disease. We propose that the increased androgen levels are of ovarian origin as adrenal androgens were normal. The reason for the slight increase of prolactin and the marked increase of gonadotropins in women with MS is speculative. As oestradiol levels, however, were within normal range, we assume that a peripheral resistance to gonadotropins combined with an abnormal central regulation causes the increased pituitary secretion.Keywords
This publication has 15 references indexed in Scilit:
- Pharmacological studies of somatostatin and somatostatin-analogues: Therapeutic advances and perspectivesLife Sciences, 1987
- Autoantibodies in sera from patients with multiple sclerosis directed against antigenic determinants in pituitary growth hormone-producing cells and in structures containing vasopressin/oxytocinJournal of Neuroimmunology, 1985
- Endokrinologische Befunde bei Patientinnen mit multipler SkleroseGeburtshilfe und Frauenheilkunde, 1981
- Interrelationships between sex hormone-binding globulin and testosterone, 5α-dihydrotestosterone and oestradiol- 7β in blood of normal menMaturitas, 1980
- Low somatostatin content in cerebrospinal fluid in multiple sclerosisActa Neurologica Scandinavica, 1980
- Estrone sulfate and dehydroepiandrosterone sulfate concentrations in normal subjects and men with cirrhosisSteroids, 1979
- Methods for multiple steroid radioimmunoassayJournal of Steroid Biochemistry, 1975
- PROLACTIN, TSH, LH AND FSH RESPONSES TO A COMBINED LHRH/TRH TEST AT DIFFERENT STAGES OF THE MENSTRUAL CYCLEClinical Endocrinology, 1974
- Further notes on disability evaluation in multiple sclerosis, with scale modificationsNeurology, 1965
- PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSISAnnals of the New York Academy of Sciences, 1965